Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic Alopecia
Clinical trial NCT07516561 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07516561
- Sponsor
- Apsen Farmaceutica S.A.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-07
- Primary completion
- 2029-08-02
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.